S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Stockholm Exchange · Sweden · Updated after 20 Oct 2026 close

Cantargia AB

CANTA · Stockholm Exchange · prices in SEK
SEK 1.340▲ +0.021 (1.59%)
Research reportHistorical data

About Cantargia AB

Cantargia AB is a biotechnology company based in Lund, Sweden, that develops antibody-based treatments for cancer. Its work centres on therapies that target a protein found on certain cancer cells and on the cells supporting tumours, aiming to help the body's immune system attack the disease. The company carries out research and clinical development of these drug candidates, working with partners and investigators in the oncology field.

Cantargia AB trades under the code CANTA on the Stockholm Exchange in Sweden, with its price quoted in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

21/ 100
Market X-Ray · price-based
Weak price profile
Ranks #792 of 911 on the Stockholm Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Sweden yet.
TrendWeak
5/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-56.2%
From 52-week high-78.4%
MomentumWeak
12/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-29.5%
6-month return-65.8%
12-month, skipping last month-37.6%
Stability (higher is calmer)Weak
19/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)74.5%
Worst drawdown, 1 year (smaller is calmer)-79.3%
LiquidityFair
67/100
Moderate trading activity.
See the numbers →
Avg daily value traded2.11M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Sweden when fundamentals data for this market is added. All Sweden stocks.
Price trend
Below its 200-day average
Versus its 50- and 200-day averages
52-week range
1.250 – 6.590
Price is 2% of the way up
Returns
−29.5% 3m · −46.5% 1y
Price returns, dividends not included
RSI (14)
38
Neutral zone

Price chart

52-wk range 1.250 – 6.590 Daily closes, split-adjusted

Signals

50-day average1.604
200-day average3.059
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)0.077

Technical summary

Daily
Bearish
2 bullish · 4 neutral · 10 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 101.32Bullish
EMA 101.34Bullish
SMA 201.39Bearish
EMA 201.40Bearish
SMA 501.60Bearish
EMA 501.58Bearish
SMA 1001.80Bearish
EMA 1001.95Bearish
SMA 2003.06Bearish
EMA 2002.43Bearish
Oscillators (daily)
RSI (14)38.47Neutral
MACD (12, 26)-0.09Bearish
Momentum (12)-4.90Bearish
Stochastic %K (14)26.55Neutral
Williams %R (14)-73.45Neutral
CCI (20)-57.28Neutral
Pivot points (classic, last session)
S3
1.29
S2
1.30
S1
1.32
Pivot
1.33
R1
1.35
R2
1.37
R3
1.39
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.

Prices are end-of-day closes in SEK. Educational only, not financial advice.